Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.02
-0.19 (-3.65%)
Apr 25, 2025, 12:40 PM EDT - Market open
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $283.30 million as of April 25, 2025. Its market cap has decreased by -55.09% in one year.
Market Cap
283.30M
Enterprise Value
-36.09M
1-Year Change
-55.09%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $283.30M, an increase of 57.39%. That is a compound annual growth rate of 4.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 294.00M | -41.72% |
| Dec 31, 2024 | 504.50M | 80.95% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.40B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |